Claims for Patent: 5,147,783
✉ Email this page to a colleague
Summary for Patent: 5,147,783
Title: | Methods to screen for ovarian cancer and myocardial infarction |
Abstract: | A monoclonal antibody against human manganese-superoxide dismutase characterized in that it is produced by a cell line which has been obtained by immunization of a mouse with human Mn-SOD and then fusion of lymphocytes obtained from the mouse with mouse myeloma cells, and has high specificity against human Mn-SOD; a method for producing a monoclonal antibody against human Mn-SOD having high specificity against human Mn-SOD, which comprises culturing the cell line obtained by immunization of a mouse with human Mn-SOD and then cell fusion of lymphocytes obtained from the mouse with mouse myeloma cells; a kit for assaying human Mn-SOD, comprising: (a) a monoclonal antibody having very high specific immuno-reactivity against human Mn-SOD; and (b) a reagent of a monoclonal antibody having very high specific immuno-reactivity against human Mn-SOD labelled with an enzyme (enzyme labelled antibody); a method for assaying human Mn-SOD use of the kit; a novel diagnostic method of human epithelial ovarian cancer, which comprises assaying the concentration of human Mn-SOD in a body fluid by use of the assay kit; and a novel diagnostic method of myocardial infarction, which comprises assaying the concentration of human Mn-SOD in a body fluid by use of the assay kit. |
Inventor(s): | Uda; Taizo (Ube, JP), Itoh; Yukikatsu (Ube, JP), Kawaguchi; Tetsuo (Ube, JP), Hifumi; Emi (Ube, JP), Taniguchi; Naoyuki (Toyonaka, JP), Suzuki; Keiichiro (Takatsuki, JP), Ishikawa; Mutsuo (Asahikawa, JP), Noji; Shirou (Tokyo, JP) |
Assignee: | Ube Industries, Ltd. (Ube, JP) |
Application Number: | 07/352,109 |
Patent Claims: | 1. A method of screening for human epithelial ovarian cancer, which comprises (a) assaying for a concentration of human Mn-SOD in a body fluid by contacting the bodily fluid with a
monoclonal antibody having a high specificity against human Mn-SOD, said monoclonal antibody not being reactive with any human albumin, human globulin, Cu and Zn-SOD, said monoclonal antibody being immobilized on a carrier, and (b) determining whether a
concentration of 130 ng/ml or more of human Mn-SOD in a bodily fluid is present as an indication of the presence of epithelial ovarian cancer.
2. The method according to claim 1, wherein the monoclonal antibody is secreted from a hybridoma selected from the group consisting of FERM-BP 1606, FERM-BP 1607 and FERM-BP 1608. 3. A method of screening for myocardial infarction, which comprises (a) assaying for a concentration of human Mn-SOD in a body fluid by contacting the bodily fluid with a monoclonal antibody having a high specificity against human Mn-SOD, said monoclonal antibody not being reactive with any of human albumin, human globulin. Cu and Zn-SOD, said monoclonal antibody being immobilized on a carrier, and (b) determining whether a concentration of 150 ng/ml of more of human Mn-SOD in a bodily fluid is present as an indication of an occurrence of a myocardial infarction. 4. The method according to claim 3, wherein the monoclonal antibody is secreted from a hybridoma selected from the group consisting of FERM-BP 1606, FERM-BP 1607 and FERM-BP 1608. |
Details for Patent 5,147,783
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Grifols Therapeutics Llc | ALBUKED, PLASBUMIN-20, PLASBUMIN-25, PLASBUMIN-5 | albumin (human) | For Injection | 101138 | 10/21/1942 | ⤷ Try a Trial | 2009-09-15 |
Baxalta Us Inc. | BUMINATE, FLEXBUMIN | albumin (human) | Injection | 101452 | 03/03/1954 | ⤷ Try a Trial | 2009-09-15 |
Csl Behring Ag | ALBURX | albumin (human) | Injection | 102366 | 07/23/1976 | ⤷ Try a Trial | 2009-09-15 |
Grifols Biologicals Llc | ALBUTEIN | albumin (human) | Injection | 102478 | 08/15/1978 | ⤷ Try a Trial | 2009-09-15 |
Instituto Grifols, S.a. | HUMAN ALBUMIN GRIFOLS | albumin (human) | Injection | 103352 | 02/17/1995 | ⤷ Try a Trial | 2009-09-15 |
Instituto Grifols, S.a. | HUMAN ALBUMIN GRIFOLS | albumin (human) | Injection | 103352 | 06/11/2003 | ⤷ Try a Trial | 2009-09-15 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.